56 related articles for article (PubMed ID: 20100115)
1. Reduced HIV-1 long terminal repeat transcription in subjects with protective interferon regulatory factor-1 genotype: a potential mechanism mediating resistance to infection by HIV-1.
Ji H; Ball TB; Ao Z; Kimani J; Yao X; Plummer FA
Scand J Infect Dis; 2010 May; 42(5):389-94. PubMed ID: 20100115
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers.
Ball TB; Ji H; Kimani J; McLaren P; Marlin C; Hill AV; Plummer FA
AIDS; 2007 May; 21(9):1091-101. PubMed ID: 17502719
[TBL] [Abstract][Full Text] [Related]
3. Role of acetylases and deacetylase inhibitors in IRF-1-mediated HIV-1 long terminal repeat transcription.
Marsili G; Remoli AL; Sgarbanti M; Battistini A
Ann N Y Acad Sci; 2004 Dec; 1030():636-43. PubMed ID: 15659847
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the signal transduction pathway leading to human immunodeficiency virus-1-induced interferon regulatory factor-1 upregulation.
Sgarbanti M; Marsili G; Remoli AL; Ridolfi B; Stellacci E; Borsetti A; Ensoli B; Battistini A
Ann N Y Acad Sci; 2004 Dec; 1030():187-95. PubMed ID: 15659797
[TBL] [Abstract][Full Text] [Related]
5. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
[TBL] [Abstract][Full Text] [Related]
6. Long-term suppression of HIV-1C virus production in human peripheral blood mononuclear cells by LTR heterochromatization with a short double-stranded RNA.
Singh A; Palanichamy JK; Ramalingam P; Kassab MA; Bhagat M; Andrabi R; Luthra K; Sinha S; Chattopadhyay P
J Antimicrob Chemother; 2014 Feb; 69(2):404-15. PubMed ID: 24022068
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
8. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
Wietzke-Braun P; Maouzi AB; Mänhardt LB; Bickeböller H; Ramadori G; Mihm S
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):991-7. PubMed ID: 16894313
[TBL] [Abstract][Full Text] [Related]
9. Functional relevance of the IRF-1 promoter polymorphism rs2549009 on transcriptional activity in a native genomic environment.
Mertens J; Ramadori G; Mihm S
Hum Mol Genet; 2010 Dec; 19(23):4587-94. PubMed ID: 20846942
[TBL] [Abstract][Full Text] [Related]
10. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
Zekri AR; Moharram RA; Mohamed WS; Bahnassy AA; Alam El-Din HM; Abo-Shadi MM; Zayed NA; El-Magzangy H; Abdel-Aziz AO; Esmat G
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):450-6. PubMed ID: 19858727
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
Mukhtar M; Duan L; Bagasra O; Pomerantz RJ
Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098
[TBL] [Abstract][Full Text] [Related]
12. IFN regulatory factor-1 bypasses IFN-mediated antiviral effects through viperin gene induction.
Stirnweiss A; Ksienzyk A; Klages K; Rand U; Grashoff M; Hauser H; Kröger A
J Immunol; 2010 May; 184(9):5179-85. PubMed ID: 20308629
[TBL] [Abstract][Full Text] [Related]
13. The X protein of HBV induces HIV-1 long terminal repeat transcription by enhancing the binding of C/EBPβ and CREB1/2 regulatory proteins to the long terminal repeat of HIV-1.
Mu Y; Yu Y; Yue X; Musarat I; Gong R; Zhu C; Liu Y; Liu F; Zhu Y; Wu J
Virus Res; 2011 Mar; 156(1-2):81-90. PubMed ID: 21237225
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species activate HIV long terminal repeat via post-translational control of NF-kappaB.
Pyo CW; Yang YL; Yoo NK; Choi SY
Biochem Biophys Res Commun; 2008 Nov; 376(1):180-5. PubMed ID: 18765232
[TBL] [Abstract][Full Text] [Related]
15. IRF-7: new role in the regulation of genes involved in adaptive immunity.
Sgarbanti M; Marsili G; Remoli AL; Orsatti R; Battistini A
Ann N Y Acad Sci; 2007 Jan; 1095():325-33. PubMed ID: 17404045
[TBL] [Abstract][Full Text] [Related]
16. TAT-mediated transcellular activation of HIV-1 long terminal repeat directed gene expression by HIV-1-infected peripheral blood mononuclear cells.
Thomas CA; Dobkin J; Weinberger OK
J Immunol; 1994 Oct; 153(8):3831-9. PubMed ID: 7930599
[TBL] [Abstract][Full Text] [Related]
17. The most frequent naturally occurring length polymorphism in the HIV-1 LTR has little effect on proviral transcription and viral replication.
Hiebenthal-Millow K; Kirchhoff F
Virology; 2002 Jan; 292(1):169-75. PubMed ID: 11878920
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma regulation of the human mimecan promoter.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
[TBL] [Abstract][Full Text] [Related]
19. Prostratin induces HIV activation and downregulates HIV receptors in peripheral blood lymphocytes.
Rullas J; Bermejo M; García-Pérez J; Beltán M; González N; Hezareh M; Brown SJ; Alcamí J
Antivir Ther; 2004 Aug; 9(4):545-54. PubMed ID: 15456086
[TBL] [Abstract][Full Text] [Related]
20. NF kappa B upstream regulatory sequences of the HIV-1 LTR are involved in the inhibition of HIV-1 promoter activity by the NS proteins of autonomous parvoviruses H-1 and MVMp.
Faisst SR; Faisst S; Grangette C; Schlehofer JR; Rommelaere J
Virology; 1993 Dec; 197(2):770-3. PubMed ID: 8249299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
